NEW YORK – Single-cell DNA analysis startup Mission Bio and biopharmaceutical firm Onconova announced today that they signed a collaboration to use Mission Bio's Tapestri platform for targeted single-cell DNA analysis to study Onconova's cancer therapy through clinical trials.